3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
28
Neoplasms
15
Carcinoma, Non-Small-Cell Lung
7
Multiple Myeloma
6
Hematologic Neoplasms
6
Neoplasm Metastasis
4
Lymphoma
4
Leukemia, Myeloid, Acute
3
Colorectal Neoplasms
3
Brain Neoplasms
3
Biliary Tract Neoplasms
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Glioma
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Adenocarcinoma, Follicular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
Paclitaxel
8
pembrolizumab
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Albumin-Bound Paclitaxel
6
Pemetrexed
4
Nivolumab
4
Irinotecan
4
Everolimus
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
vosaroxin
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
trametinib
×
Clear all
No trials found.